ReviewClinical microbiology reviews2006

Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing.

M A Pfaller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.